In breast cancer, elevated Retinoid X Receptor Gamma (RXRG) levels in tumor cells correlate with better outcomes, especially in estrogen receptor (ER)-positive cases, suggesting RXRG as a prognostic marker for ER-positive breast cancer patients [62]. Here, ESR1 is linked to neoplasm.